DRI Healthcare Trust (TSE:DHT.UN) Price Target Raised to C$23.00

DRI Healthcare Trust (TSE:DHT.UN) had its price target boosted by analysts at Stifel Nicolaus from C$22.00 to C$23.00 in a research note issued on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 41.63% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the stock. Scotiabank upped their price target on shares of DRI Healthcare Trust from C$25.00 to C$30.00 and gave the company a “sector outperform” rating in a research report on Tuesday. National Bank Financial upped their price target on shares of DRI Healthcare Trust from C$22.50 to C$23.50 and gave the company an “outperform” rating in a research report on Tuesday. Five research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, DRI Healthcare Trust currently has an average rating of “Buy” and an average target price of C$22.30.

DRI Healthcare Trust Stock Performance

Shares of TSE:DHT.UN traded up C$0.10 during mid-day trading on Tuesday, hitting C$16.24. The stock had a trading volume of 118,020 shares, compared to its average volume of 42,893. The company has a market cap of C$893.48 million, a PE ratio of -18.04 and a beta of 0.35. DRI Healthcare Trust has a 12-month low of C$12.51 and a 12-month high of C$17.69. The company’s 50 day moving average is C$16.59 and its 200-day moving average is C$16.28.

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S.